Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PANTOPRAZOLE ANHYDROUS Cause Therapy non-responder? 120 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 120 reports of Therapy non-responder have been filed in association with PANTOPRAZOLE ANHYDROUS. This represents 8.4% of all adverse event reports for PANTOPRAZOLE ANHYDROUS.

120
Reports of Therapy non-responder with PANTOPRAZOLE ANHYDROUS
8.4%
of all PANTOPRAZOLE ANHYDROUS reports
105
Deaths
115
Hospitalizations

How Dangerous Is Therapy non-responder From PANTOPRAZOLE ANHYDROUS?

Of the 120 reports, 105 (87.5%) resulted in death, 115 (95.8%) required hospitalization, and 116 (96.7%) were considered life-threatening.

Is Therapy non-responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PANTOPRAZOLE ANHYDROUS. However, 120 reports have been filed with the FAERS database.

What Other Side Effects Does PANTOPRAZOLE ANHYDROUS Cause?

Pain (633) Rheumatoid arthritis (572) Asthma (568) Pyrexia (556) Hypertension (555) Rash (551) Headache (550) Fatigue (539) Dyspnoea (509) Hypersensitivity (498)

What Other Drugs Cause Therapy non-responder?

ETANERCEPT (3,472) APREMILAST (3,360) METHOTREXATE (2,965) RITUXIMAB (2,731) ADALIMUMAB (2,595) PREDNISONE (2,563) TREPROSTINIL (2,289) INFLIXIMAB (2,122) TOCILIZUMAB (1,775) HYDROXYCHLOROQUINE (1,699)

Which PANTOPRAZOLE ANHYDROUS Alternatives Have Lower Therapy non-responder Risk?

PANTOPRAZOLE ANHYDROUS vs PANTOTHENIC ACID PANTOPRAZOLE ANHYDROUS vs PAPAVERINE PANTOPRAZOLE ANHYDROUS vs PARACETAMOL PANTOPRAZOLE ANHYDROUS vs PARATHYROID HORMONE PANTOPRAZOLE ANHYDROUS vs PARECOXIB

Related Pages

PANTOPRAZOLE ANHYDROUS Full Profile All Therapy non-responder Reports All Drugs Causing Therapy non-responder PANTOPRAZOLE ANHYDROUS Demographics